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GENERAL INTRODUCTION 
Vitamin E Supplementation and Plasma Cholesterol 
Elevated plasma cholesterol is well established as a factor in the 
development of atherosclerosis. Clinical trials have shown an association 
between reduced total plasma cholesterol and reduced coronary heart disease 
(CHD) in humans (1,2) and a 1% reducdon in plasma cholesterol was 
associated with an approximate 2% reduction in CHD. 
Brown and Goldstein (3) and Mahley and Innerarity (4) have shown 
that cholesterol homeostasis is closely related to plasma lipoprotein 
metabolism. Plasma high-density lipoprotein cholesterol (HDL-C) has an 
inverse relation with the risk of CHD (5,6). There is persuasive evidence that 
this protective association is causal because the role of HDL is to transport 
cholesterol from peripheral tissues to the liver where it is catabolized and 
excreted. In contrast, the role of low-density lipoprotein (LDL) is to transport 
cholesterol from liver to peripheral tissues and regulate de novo cholesterol 
synthesis at these sites. Therefore, there is great interest in factors that alter 
these lipoprotein concentrations. 
Studies of the relationships between vitamin E and cholesterol 
distribution and concentration in plasma lipoproteins have given equivocal 
data. Sundaram et al. (7), Behrens et al. (8) and Takahashi et al. (9) have 
proposed that vitamin E is transported by the blood lipoproteins. Vitamin E 
has been reported by several laboratories to affect cholesterol distribution in 
lipoproteins. For 21 days, Sundaiam et al. (7) studied 26 patients with 
clinically confirmed mammary dysplasia and five age-matched controls. The 
volunteers took 600 mg d,l-a-tocopherol per day, and serum samples were 
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collected before and after the treatment. As a result of therapy, HDL-
cholesterol increased and LDL-cholesterol decreased. Chupukcharoen et al. 
(10) determined the effect of vitamin E deficiency on lipoprotein cholesterol 
distribution. An increase in plasma cholesterol was detected in LDL and very 
low density lipoprotein (VLDL), but not in the HDL fraction of plasma 
lipoproteins. Phonpanichrasamee et ai. (11) reported that an oral 
supplementation of 600 mg d,l-a-tocopherol acetate every other day exerted a 
hypocholesterolemic effect on LDL-cholesterol and VLDL-cholesterol in 
rabbits fed an atherosclerosis-promodng diet containing 0.25% or 0.5% 
cholesterol. W'ojciaki et al. (12) found that selenium and/or vitamin E 
remediation of deficiency had an elevating effect on HDL-cholesterol in 
rabbits. 
However, in another study vitamin E had little effect on plasma 
lipoproteins. Hatam and Kayden (13) studied 11 subjects, 6 subjects with 
normal lipid values, 4 subjects with hypercholesterolemia and 1 subject with 
hypertriglyceridemia for six weeks. Subjects were supplemented with 800 mg 
of vitamin E daily. Fasting blood samples were analyzed before vitamin E 
supplementation and after approximately three and six weeks of daily 
supplementation. Although the serum cholesterol concenti'ation did decrease 
slightly in some subjects with vitamin E supplementation, the percentage of 
cholesterol in the HDL fraction was not significantly altered. Thus it appeai'ed 
from this study that a-tocopherol did not influence the distribution of 
cholesterol in the lipoproteins of normal or hyperlipoproteinemic patients. 
Howard et al. (14) determined the effect of vitamin E supplementation on 
HDL-cholesterol level. Thirty-nine adult volunteers were involved in this 
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study and 600 mg of oral d,l-a-tocopherol acetate were given daily for 30 
days. No significant change in HDL-cholesterol was noted after 30 days of 
oral intake of vitamin E. Jacques et al. (15) showed that vitamin E 
supplementation did not affect HDL-cholesterol in the elderly who consumed 
greater than or equal to 10 times the recommended dietary allowance (RDA). 
Stampfer et al. (16) conducted a randomized, double-blind, placebo-controlled 
clinical trial of vitamin E administration (800 mg/day) for 16 weeks. Thirty 
volunteers aged 30-60 years were involved in diis study. Fasting HDL-
cholesterol was measured at 8 and 16 weeks, and vitamin E had no effect on 
HDL-cholesterol. Also, in other human studies conducted by Kalbfleisch et 
al. (17) and Kesaniemi and co-workers (18), vitamin E did not show any effect 
on HDL-cholesterol concentrations. 
Hepatic cholesterol 7a-hydroxylase is the rate-limiting enzyme in the 
degradation of cholesterol through bile acid synthesis (Fig. 1) (19). 
Chupukcharoen et al. (10) studied hepatic cholesterol 7a-hydroxylase activity 
in control and vitamin E-deficient rabbits. The activity of cholesterol 7a-
hydroxylase in vitamin E-deficient rabbits was approximately one-fifth that of 
control rabbits. Also, Phonpanichrasamee et al. (11) reported that rabbits with 
oral supplementation of 600 mg d,l-a-tocopherol acetate every other day for 8 
weeks showed a 4-5 fold increase in hepatic cholesterol 7«-hydroxylase 
activity compared with the control rabbits. Because greater plasma 
cholesterol results in greater incidence of atherosclerosis, it is important to 
determine the role of vitamin E in cholesterol metabolism. 
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Vitamin E and Lipid Peroxidation 
Dietary antioxidants have attracted increasing attention in the past few 
years because of their suspected role in health and disease. Numerous trials 
are currently in progress to demonstrate the potential effects of antioxidant 
supplementation in humans with a variety of diseases, such as cancer (20). 
Consumption of marine oils has been linked to a low incidence of coronary 
heart disease (21,22). However, fish oils are rich in unsaturated n-3 fatty 
acids that are very susceptible to lipid peroxidation. A high dietary intake of 
n-3 fatty acids might overwhelm the normal antioxidant defenses, thus 
potentially increasing the requirement for dietary antioxidants. 
The basic process of lipid peroxidation can be described in several 
stages (Fig. 2). Vitamin E (a-TH) is believed to inhibit lipid peroxidation via 
donation of a hydrogen atom to a lipid peroxyl radical (R00-) forming a lipid 
hydroperoxide (ROOH) and reversibly oxidized vitamin E (a-T-) (23). 
Oxidized vitamin E is reduced to vitamin E by glutathione (GSH) as 
suggested by Reddy et al. (24). Reddy and coworkers (24) also provided 
preliminary evidence for the involvement of a membrane protein in this 
mechanism. The membrane protein was shown to be specific for GSH and 
relatively unstable. It will be referred to as GSH-dependent vitamin E 
reductase. 
Vitamin E has a consistently inhibitory effect on lipid peroxidation 
regardless of the lipid peroxidation products measured. For example, the 
production of pentane (25), ethane (26), thiobaibituric acid-reactive 
substances (TEARS), conjugated dienes (CD), headspace hexanal and total 
volatiles (TOV) (27) in rats is reduced by vitamin E supplementation within 
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the ranges of 35 to 200 mg vitamin E/kg diet. 
Macrophage-derived foam cells are an important indicator of the early 
atherosclerotic lesion (28,29). Oxidatively modified LDL (30) can cause 
foam cell formation via uptake through the macrophage acetyl-LDL receptor. 
Sparrow et al. (31) speculated that the introduction of lipid hydroperoxides 
into an LDL particle can initiate biological modification of the lipoprotein. 
The protective role of vitamin E in atherosclerosis could be via its inhibition 
of lipid peroxidation therefore permitting less oxidatively modified LDL and 
foam cell formation. 
1. Initiation: RH—>R-
2. Oxidation; R + O2—>R00-
3. Propagation: ROO + RH—> R 4- ROOH 
4. ROO + a-TH^ ROOH + a-T-
5. a-T- + GSH^a-TH + 1/2GSSG 
Figure 2. Stages of autoxidation and inhibition of autoxidation by vitamin E 
Biochemistry of Prostanoids 
"Prostanoids" are the collective name for unsaturated lipids derived 
from arachidonic acid (C20:4n-6) or similar polyunsaturated fatty acid 
precursors, via the cyclo-oxygenase metabolic pathway (Fig. 3) (32). 
Arachidonic acid is always derived from the 2-position of phospholipids in the 
plasma membrane as a result of phospholipase A2 activity (33,34,35). 
Prostanoids have 20 carbon atoms and include a five-member ring. Their 
three precursor fatty acids contain at least three double bonds and give rise to 
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3 groups of eicosanoids characterized by the number of double bonds in the 
side chains. This group of compounds consists of prostaglandins and 
thromboxanes. Variations in the substituent groups attached to the rings give 
rise to different types in each series of protaglandins and thromboxanes, 
labeled A, B, etc. 
Thromboxanes are synthesized in platelets and cause vasoconstriction 
and platelet aggregation upon release. Prostacyclins (PGI2) are produced by 
blood vessel walls and inhibit platelet aggregation (36). Thus, thromboxanes 
and prostacyclins are antagonistic. The balance between thromboxanes and 
prostacyclins is important, because vasoconstriction and platelet aggregation 
are prothrombogenic and can be important to acute atherosclerosis-related 
diseases such as myocardial infarction and stroke (37,38,39). 
Measurement of prostacyclin in a system generating the compound in 
vitro is often done by immediate assay of its biologic activity, such as 
measurement of induced relaxation of vessels. Because its half-life is only 
about 2 min, this approach is generally impossible for measurement of the 
generation of prostacyclin in vivo and the immediate hydrolysis product, 6-
keto-PGFioc, has been used for this purpose (40). To assay thromboxane 
production in vivo, the most common approach is to measure the stable 
hydrolysis product, TXB2, in plasma (40). 
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Figure 3. Synthesis of Prostaglandins and Thromboxanes (32) 
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Vitamin E and Prostanoid Synthesis 
In addition to its role as a lipid antioxidant, vitamin E also plays a 
significant role in maintenance of normal function of the blood and vascular 
system (41,42,43). Vitamin E exerts its effect on prostacyclin and 
thromboxane production via its influence on phospholipase and the 
oxygenases acting on arachidonic acid. The basic process of vitamin E's 
effect on prostanoid synthesis as proposed by Panganamala and Cornwell (41) 
can be described in several stages (Fig. 4). Panganamala and Cornwell found 
that vitamin E can inhibit phospholipase A2 activity and thereby cause the 
release of less arachidonic acid. On the other hand, vitamin E enhances 
cyclooxygenase activity. Furthermore, vitamin E can enhance prostacyclin 
synthetase by blocking the inhibitory effect of hydroperoxy fatty acids on 
protacyclin synthetase. 
The role of vitamin E in prostanoid synthesis is controversial. 
Prostacyclin generation is inhibited by hydroperoxy arachidonic acid (44), 
raising the possibility that vitamin E might enhance prostacyclin production 
by blocking the inhibitory effects of lipid peroxides on prostacyclin synthetase 
(41). In rat testes (45), vitamin E deficiency diminished 6-keto-PGFi a 
production. However, in human studies, Stampfer et al. (46) have shown no 
effect of vitamin E on ô-keto-PGFia production, while, Swartz et al. (47) 
have reported decreased plasma PGI2 in healthy adult subjects supplemented 
with vitamin E. 
Studies on the effect of dietary vitamin E on thromboxane production 
have not resulted in a consistent picture. For example, Karpen et al. (48) 
found that platelets from vitamin E-deficient rats produced more thromboxane 
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A2 than platelets from vitamin E-supplemented rats when the platelets were 
challenged with collagen. Stampfer et al. found no effect of vitamin E 
supplementation on thromboxane A2 production (46). Hwang and Donovan 
found increased concentrations of thromboxane B2 in collagen-stimulated 
whole blood but not platelet-rich plasma of vitamin E-deflcient rats (49). 
Contradictory results obtained by different laboratories could be due to 
different vitamin E dosage used in the ranges of 0 to 1000 mg/kg diet, 
differences in feeding period from 8 to 23 weeks, species variation, for 
example rats, rabbits and humans and techniques of tissues sampling and 
preparation. 
PHOSPHOLIPIDS 
5,8.11.14-20.4 
HYDROPEROXY 
FATTY ACIDS -
ENDOPEROXIDES 
HYDROXY 
FATTY ACIDS 
MDA 
or RADICALS 
PROSTACYCLIN PROSTAGLANDINS 
VITAMIN E 
VITAMIN E 
THROMBOXANE 
Figure 4. A model for the effects of vitamin E on the biosynthesis of 
prostanoids from arachidonic acid (41) 
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Dietary Fat and Platelet Function 
It is well established that dietary lipids induce extensive modifications 
in the fatty acid composition of platelets (50,51,52). Such modifications can 
cause a variety of functional changes, influencing, for example, membrane 
fluidity (53), platelet aggregability (54) and the biosynthesis of eicosanoids 
(55,56,57). Piche and Mahadevappa (50) demonstrated that platelets of rats 
fed animal fat (lard or cod liver oil) contained significantly lower levels of 
linoleic acid, 18:2 (n-6), than did platelets from rats fed fats of vegetable 
origin (corn oil, soybean oil or canola oil) for 7 weeks. When rats were fed 
diets composed of corn oil, olive oil, hydrogenated coconut oil and 
hydrogenated palm oil which supplied 1.3 (group 1) or 13.2 (group 2) en% 
from polyunsaturated fatty acids (18:2 +18:3), differences in dietary fat 
changed the fatty acid composition (%) of the platelet lipids (51). Diets high 
in saturated fatty acids markedly increased rat platelet sensitivity to thrombin 
(51). Rats fed the saturated fats (group 1) as compaied with those fed the 
polyunsaturated fats (group 2), had a significantly greater, relative content of 
18:ln-9, 20:3n-9, 20:3n-6 and 22:3n-6 at the expense mostly of 18:2n-6, 
20:2n-6 and 22:4n-6. Platelet phospholipid fatty acid profile can be 
manipulated by dietary fat (52). When rats were fed a fat-free diet, 
endogenous n-9 eicosatrienoic acid was the major polyunsaturated fatty acid 
in liver, plasma and platelets while a high 20:3 (n-9)/20:4 (n-6) ratio was 
found, a sign of essential fatty acid deficiency (58). After fat (com oil or fish 
oil) was substituted for 5% sucrose in the diet, the platelet phospholipid fatty 
acids, 20:4 (n-6), 20:5 (n-3) and 22:6 (n-3), increased and reached a peak at 
day 12. 
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Platelet membrane fluidity also can be affected by dietary lipid (53). 
Membrane fluidity has been defined by Van Blitterswijk et al. (59) as the 
reciprocal of the lipid structural order parameter (rg). Lower values of rg 
measured by fluorescence polarization, indicate decreased structural order 
parameters and increased membrane fluidity. The administration of a diet rich 
in sunflower seed oil, 50 en% vs 5 en%, significantly enhanced the overall 
fluidity of platelet membranes, measured with the hydrophobic probe 1,6-
diphenyl-l,3,5-hexatriene (53). 
It also has been found that platelet response to aggregators was affected 
by dietary fat. In a rat model, using a loop-shaped polyethylene cannula in the 
abdominal aorta to study aiterial thrombosis, it appeared that sunflower seed 
oil, and its linoleic acid fraction in particular, lowered the tendency toward 
arterial thrombosis in a dose-dependent manner (60). In a further series of 
experiments using rats (61), the anti-thrombotic effect of linoleic acid was 
confirmed. Moreover, long-chain saturated fatty acids containing fourteen or 
more carbons increased arterial thrombosis in a dose-dependent manner. In 
rabbits fed corn oil, the sensitivity toward collagen and aiachidonic acid-
induced platelet aggregation was lowered when compared to aggregation in 
butter-fed animals (62). In a human study, platelet aggregation in response to 
thrombin and adenosine diphosphate was increased in a group of French 
farmers eating a high saturated fat diet, compared with a second group eating 
a diet containing less saturated fat (63). However, Winocour et al. (64) could 
not find an effect of dietary fat on platelet function in rats. Diets containing 
1.5% safflower or corn oil or 16% milk fat were used in this study. Dietary 
fat did affect platelet phospholipid fatty acid composition. But no effect on in 
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vitro platelet function or in vivo platelet survival in response to indwelling 
aortic catheters was observed. 
Dietary Fat and Eicosanoid Synthesis 
In 1968, Lands and Samuelsson (65) proposed that eicosanoid synthesis 
required the free, nonesterified form of arachidonate, because the oxygenase 
will not act on substrate bound to phospholipid. Neufeld et al. (66) and 
Wilson et al. (67) demonstrated that the resting platelet contained no free 
arachidonate, perhaps related to the activity of an arachidonoyl coenzyme A 
syndietase which mediates the ti ansfer of free ai'achidonate into phospholipid. 
Platelets contain little or no free substrate and eicosanoid synthesis requires 
the release of free substrates from phospholipids. Arachidonic acid is formed 
in the liver and released into the plasma. Many tissues lack desaturase 
enzymes and cannot convert dietary linoleic acid into ai'achidonic acid. Both 
platelets and endothelial cells lack desaturase enzymes, and so take up 
arachidonic acid from plasma (68,69). Because ai'achidonic acid is the 
precursor of many eicosanoids, and since platelets actively incorporate 
arachidonic acid into their phospholipid, die platelet is a good model in which 
to study the effects of dietary fat on eicosanoid synthesis. 
It has been estimated that the American diet (70) contains less than 0.2 
en% arachidonic acid and approximately 6 en% linoleate; thus one can 
conclude that most tissue arachidonic acid is derived from dietary linoleate. 
Because arachidonic acid is the direct precursor of many eicosanoids, dietary 
linoleate plays an important role in eicosanoid synthesis. Dupont et al. (55) 
studied the effect of dietary linoleate on thromboxane B2 (TXB2) synthesis in 
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incubated blood from female Sprague-Dawley rats. Zero to 27 en% linoleate 
and 40% of energy (en%) from fat was fed to rats for 6 months. The various 
en% from linoleate were obtained by the combination of different ratios of 
beef tallow, soybean oil and safflower oil. TXB2 synthesis increased as 
linoleate increased from 0 to 2% of kcal, however, between 2 and 8 en%, 
reduced eicosanoid synthesis was observed. Between 10 and 27 en% 
linoleate, TXB2 synthesis returned to the level at 2 en% linoleate. The 
conclusion reached by Dupont et al. (55) was that prostaglandin synthesis 
appeared to be abnormally regulated with less than 8 en% linoleate in a 40% 
fat calorie diet. Sullivan and Mathias (56) determined the effect of dietary fat 
on platelet PG-producing activity. Beef tallow, com oil and safflower oil 
were used to supply 40% fat calories and 0, 0.4, 14, 22 and 29 en% linoleate. 
Diets enriched with larger amounts of linoleate did not produce further 
increases in platelet PG synthesis but remained unchanged after reaching peak 
production at 0.4 en% linoleate. On the other hand, serum TXB2 levels 
declined to levels found during essential fatty acid deficiency when linoleate 
was increased to 14 en% and stayed depressed as linoleate increased to 29 
en%. Apparently, excess dietaiy linoleate did not increase eicosanoid 
synthesis, probably because eicosanoid precursors did not increase in the 
platelet. Although linoleate is the precursor of arachidonic acid, it is also a 
potent inhibitor of TXA2 synthesis in the platelet. The relationship between 
dietary linoleate and TX synthesis in cardiac tissue found by Mathias and 
Dupont (57) was similai* to the results of Sullivan and Mathias (56). Based on 
the study of Mathias and Dupont (57), the relationship between dietary 
linoleate and 6-keto-PGFia synthesis appears to be tissue-specific, because 
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the same results were not produced in different tissues. Perhaps the rate of 
incorporation of linoleate into phospholipid differs among various tissues, or 
the inhibitory effect of linoleate on PG synthetases is different among various 
tissues. 
Steel et al. (71) conducted a short-term feeding study using 10, 30 and 
50 en% fat from beef tallow, olive oil, peanut oil and butter. Butter- and beef 
tallow-feeding reduced aortic PGI2 production and collagen-induced TXA2 
production in a dose-dependent manner as the level of fat in the diet increased. 
Decreases in aortic PGI2 and collagen-induced TXA2 production were 
paralleled by similar decreases in aortic and plasma phospholipid arachidonic 
acid content. As a result of dietary treatments, only the most saturated fats, 
butter and beef tallow, had significant inhibitory effects on eicosanoid 
synthesis. Similar effects of saturated fat on eicosanoid synthesis were 
observed by O'Dea et al. (72) who fed rats with 10%, 30% or 50% energy as 
fat predominantly from butter or lard. Prostacyclin production in the 
abdominal aorta and the mesenteric aitery fell in a concentration-dependent 
manner in butter-supplemented rats. However, lard did not affect PG 
production. These results indicated that butter had a greater inhibitory effect 
on eicosanoid synthesis than did lard, perhaps reflecting a difference in their 
P/S ratios. 
Steinberg et al. (73) determined the effect of dietary lipids on serum and 
urine prostaglandin concentrations. The diets provided 40 en% as fat, and 0.4, 
14, 21, 22 and 29 en% linoleate. The results showed that the 6-keto-PGFia 
and TXB2 levels in serum and urine did not differ significantly with dietary 
treatment. Also, Fine et al. (74) demonstrated that dietary linoleate level did 
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not significantly affect serum PG levels. The results were not consistent with 
those of Dupont et al. (55), Sullivan and Mathias (56) and Mathias and 
Dupont (57). 
Although the effect of dietary fat on eicosanoid synthesis has not been 
consistent, this observation can be attributed to a variety of factors. The 
amount of dietary fat and duration of the experiments were not identical. 
Additionally, the mechanisms of conversion of linoleate to arachidonate, 
arachidonic acid deposition in tissues, long chain polyunsaturated fatty acid 
turnover and release of arachidonic acid may differ due to diets (75,76,77). 
Other factors such as competition between cyclooxygenase and lipoxygenase 
and kinetic properties of eicosanoid synthetases may also be affected by 
dietary factors. In addition, other nutrients such as vitamin E may also play a 
role in PG synthesis. 
Dietary Fat and Phospholipase A2 Activity 
Lagarde et al. demonstrated that platelet phospholipase A2 was located 
in the inner membranes of the platelets and the inner membranes had a higher 
content of phosphatidylcholine (PC) and phosphatidylinositol (PI) (78,79). 
Bills et al. (80) reported that radioactive arachidonate was preferentially 
incorporated into platelet PI and PC in platelet-rich plasma through 
arachidonoyl coenzyme A synthetase. Bills et al. (81) also showed that in 
platelets upon stimulation by thrombin, labeled aiachidonate was lost from 
platelet PI and PC. So the fatty acid composition of PI and PC can be a 
determinant of arachidonic acid metabolism. Ballou and Cheung (82) 
described an inhibitor of phospholipase A2 activity in platelet lysates. The 
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inhibitor appeared to be a lipid, because it was heat-stable, insensitive to 
trypsin and extractable in chloroform-methanol. Later, the inhibitor was 
shown to be a mixture of unsaturated fatty acids, palmitoleic acid (16:1), oleic 
acid (18:1), linoleic acid (18:2), linolenoic acid (18:3) and arachidonic acid 
(20:4) (83). Momchilova et al. (84) conducted a study to determine the effects 
of a highly unsaturated diet (HUD) (15% w/w sunflower oil) and a highly 
saturated diet (HSD) (15% w/w hydrogenated sunflower oil) on phosphohpase 
A2 activity. The substrate used for phosphohpase A2 activity of liver plasma 
membranes of rats was l-acyl-2-[14c]hnoleoyl-sn-glycerophosphocholine. 
Hepatic phosphohpase A2 activity was significantly higher in rats fed HUD 
than in rats fed HSD. However, the degree of saturation was not shown and 
the presence of trans fatty acids was not deteiTnined in diets, so it is possible 
that more than one dietary factor caused the results. There were significant 
differences in the fatty acid composition of plasma membrane PC of HUD or 
HSD fed rats. Palmitoleic acid (16:1) and oleic acid (18:1) were significantly 
greater in plasma membrane PC of HSD fed rats, but Unoleic acid (18:2) and 
arachidonic acid (20:4) were significantly greater in plasma membrane PC of 
HUD fed rats. Dietary fat could affect phospholipase A2 activity via its effect 
on fatty acid composition of membranes where phospholipase A2 resides. 
Fatty acid effects on membrane-bound proteins could be due to three 
mechanisms (1) direct effects on protein structure and/or mobility; (2) 
modification of protein function through posttranscriptional, covalent binding 
of fatty acids, or complex lipids; and (3) the potential of the fatty acids (e.g., 
arachidonic acid ) to be substrates for synthesis of bioactive metabolites (85). 
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Dietary Fat and Cholesterol 
It is well established that polyunsaturated fatty acids are 
hypocholesterolemic in humans and animals. Ibrahim and McNamara (86) 
conducted a study in guinea pigs to investigate the effects of saturated fat 
(lard) and unsaturated fat (com oil) on plasma cholesterol level when diets 
supplied 20 en% as fat. In comparison to the lard diet, the corn oil diet 
produced a 34% reduction in plasma total cholesterol level (p<0.02) and a 
40% lower triacylglycerol level (p<0.02). Also, feeding the corn oil diet 
decreased the percent cholesterol ester in both LDL and VLDL compared to 
feeding the lard diet. The results of this study were consistent with that of 
Shepherd et al. (87) who determined the effects of saturated and 
polyunsaturated fats on the chemical composition of lipoproteins. The fats 
supplied 40% energy. The polyunsaturated fat lowered both plasma 
cholesterol (23%, p<0.001) and triglyceride (14%, p<0.001) levels. The 
reduction in plasma cholesterol primarily resulted from a fall in LDL 
cholesterol (23%, p<0.001), although decreases also were detected in VLDL 
and HDL cholesterol. 
We hypothesized that increasing dietaiy linoleate content could increase 
TXA2 and PGI2 synthesis, while dietaiy vitamin E supplementation could 
inhibit TXA2 synthesis and stimulate PGI2 synthesis, and that increasing 
dietary hnoleate could lower serum cholesterol and tiiglyceride levels and 
dietary vitamin E supplementation could increase serum HDL-cholesterol. 
TXA2 and PGI2 are important to platelet and vascular functions which are 
related to the development of heart disease. Cholesterol and triglyceride have 
important roles in the pathogenesis of heait diseases. Heai t disease is 
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responsible for the majority of deaths in the United States and most 
industrialized countries. It is important to study dietary factors such as fat and 
vitamin E to determine the extent to which these nutrients can affect the risk 
of heart disease. 
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Explanation of Dissertation Format 
This dissertation is composed of two papers, each of which has its own 
abstract, introduction, materials and methods, results, discussion, and 
literature cited. The first paper reports the influences of increasing dietary 
linoleate and vitamin E supplementation on platelet fatty acid composition, 
platelet vitamin E, lipid peroxidation, phospholipase A2 activity and 
TXA2/PGI2 status. The second paper is a report of the influences of 
increasing dietary linoleate and vitamin E supplementation on semm vitamin 
E and lipid concentrations. These papers will be submitted to scientific 
journals for publication, with modifications to meet the journal's fonnat 
requirements. Following these papers are the general summary of this 
dissertation and following the general summary is the literature cited in the 
general introduction and general summary. For both papers, the first author 
will be the Ph.D. candidate, Haw-Wen Chen. 
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PAPER I. INFLUENCE OF INCREASING DIETARY LINOLEATE 
AND VITAMIN E SUPPLEMENTATION ON 
THROMBOXANE AND PROSTACYCLIN STATUS IN 
MALE SPRAGUE-DAWLEY RATS 
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ABSTRACT 
The present study was conducted to determine whether increasing 
dietary linoleate and vitamin E supplementation interact to maintain a 
relatively andthrombogenic rado of thromboxane : prostacyclin. The 
influence of increasing dietary linoleate and d,l-a-tocopheryl acetate (vitamin 
E) on platelet fatty acid composition, phospholipase A2 activity, lipid 
peroxidation, serum thromboxane B2 (TXB2), 6-keto-prostaglandin Fia (6-
keto-PGFia) and aortic ô-keto-PGFia concentrations was studied in 72 
weanling male Sprague-Dawley rats. Rats were fed semipurified diets 
containing 11 or 18% of energy from linoleate (en% linoleate) and graded 
levels (0,100 or 5000 ppm) of vitamin E for 10 weeks. Vitamin E status was 
confirmed by platelet vitamin E level. Rats fed no vitamin E had the lowest 
platelet vitamin E and rats fed 5000 ppm vitamin E had the greatest platelet 
vitamin E (p<0.05). Lipid status was verified by platelet fatty acid 
composition. Platelet C18:ln-9 (oleic acid) was significantly greater in the 11 
en% linoleate group than in the 18 en% linoleate group, and platelet C18:2n-6 
(linoleic acid) was significantiy greater in the 18 en% linoleate group than in 
the 11 en% linoleate group (p<0.05). Increasing dietai'y linoleate from 11 to 
18 en% had no adverse effect on thrombogenic potential as reflected in serum 
TXB2/6-keto-PGFia ratio. Serum TXB2 level and platelet lipid peroxidation 
(TBARS) were significantly greater in the vitamin E-deficient group than in 
other groups (p<0.05). Vitamin E supplementation had no protective effect on 
tiirombosis based on serum TXB2/6-keto-PGFia ratio. There was no 
interaction between increasing dietary linoleate and vitamin E 
supplementation on thrombogenic potential, as reflected by eicosanoid status, 
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however, vitamin E deficiency may be an important stimulator of 
thrombogenesis. The treatments had no effect on food intake, body weight 
gain, platelet phospholipase A2 activity, serum 6-keto-PGFia and aortic 6-
keto-PGFioc concentrations. 
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INTRODUCTION 
In addition to its role as a lipid antioxidant, vitamin E also plays a 
significant role in maintaining the normal function of the blood and vascular 
system (1,2,3)- Vitamin E affects prostacychn and thromboxane synthesis via 
its influence on phospholipase and the prostaglandin synthetase acting on 
arachidonic acid. Thromboxanes are synthesized in platelets and cause 
vasoconstriction and platelet aggregation upon release. Prostacyclins (PGI2) 
are produced by blood vessel walls and inhibit platelet aggregation. These 
prostaglandins could have an important role in the pathogenesis of 
cardiovascular disease (4,5,6) via their effect on the platelet and vascular 
system. 
The role of vitamin E in prostaglandin synthesis is contioversial. 
Prostacyclin generation is inhibited by hydroperoxy ai'achidonic acid (7). 
Vitamin E might enhance prostacychn production by blocking the inhibitory 
effect of lipid peroxides on prostacyclin synthetase (1). In rat testes (8), 
vitamin E deficiency caused decreased 6-keto-PGFia production. However, 
in human studies, Stampfer et al. (9) showed no effect of vitamin E on 6-keto-
PGFia production, whereas Swartz et al. (10) reported decreased plasma PGI2 
levels in healthy adult subjects supplemented with vitamin E. Although the 
effect of vitamin E on thromboxane production has been studied by many 
laboratories, the effect has not been consistent. Kai*pen et ah (11) found that 
platelets from vitamin E-deficient rats, when challenged with collagen, 
produced more thromboxane A2 than platelets from vitamin E-supplemented 
rats. Stampfer (9) found no effect of vitamin E on thromboxane A2 
production. Hwang and Donovan (12) found increased concenti*ations of 
25 
thromboxane B2 in collagen-stimulated whole blood but not in platelet-rich 
plasma of vitamin E-deficient rats. 
It has been estimated that the American diet (13) contains less than 0.2 
en% arachidonic acid and approximately 6 en% linoleate suggesting that most 
of the tissue arachidonic acid is derived from dietary linoleate. Because 
arachidonic acid is the direct precursor of many prostaglandins, dietary 
linoleate must play an important role in prostaglandin synthesis. The role of 
linoleate in prostaglandin synthesis is complicated. It is not only the precursor 
for prostaglandins but it decreases arachidonic acid in the phospholipid 
fraction (14,15) and inhibits phospholipase A2 activity (16). The effects of 
dietary linoleate on prostaglandin synthesis have been studied by many 
laboratories (17,18) but results have been not consistent. Dupont et al. (17) 
fed rats with 0 to 27 en% linoleate and 40 en% fat. TXB2 synthesis increased 
as linoleate increased from 0 to 2 en% linoleate, however, between 2 and 8 
en% linoleate, reduced eicosanoid was observed. Between 10 and 27 en% 
linoleate, TXB2 synthesis returned to the level at 2 en% linoleate. Sullivan 
and Mathias (18) used 0, 0.4, 14, 22 and 29 en% linoleate and 40 en% fat. 
Platelet PG synthesis reached peak production with 0.4 en% linoleate. Semm 
TXB2 levels declined to levels found during essential fatty acid deficiency 
when linoleate was increased to 14 en% and stayed depressed as linoleate 
increased to 29 en%. 
We hypothesized that increasing dietary linoleate could increase TXA2 
and PGI2 synthesis because of the precursor role of linoleate for arachidonate, 
and vitamin E supplementation could inhibit TXA2 synthesis and stimulate 
PGI2 synthesis. This present study reports the involvement and interactions of 
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increasing dietary linoleate and vitamin E supplementation in thromboxane 
and prostacyclin status, and therefore, in thrombogenic potential. 
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MATERIALS AND METHODS 
Animals and diets 
Seventy-two weanling male Sprague-Dawley rats (Harlan Sprague-
Dawley, Indianapolis, IN) weighing 50-60 g were individually housed in 
stainless cages on a 12-h light-dark cycle. The room was maintained at 22^C 
and approximately 50% humidity. Rats were randomly assigned to 
experimental diets in a randomized block experimental design, and the blocks 
represented the days when the rats were sacrificed and samples were 
processed. 
The experimental diets were nutritionally complete and supplied 30% of 
energy (en%) as fat (Table 1). Diets supplied 0, 100 or 5000 mg d,l-a-
tocopheryl acetate/kg of diet. Dietary fat was composed of different 
proportions of tocopherol-stripped corn oil and tocopherol-stripped laid to 
provide 11 or 18 en% linoleate, with cholesterol added as required to provide 
equal amount of cholesterol in all diets. Fatty acid composition of fat sources 
was analyzed by gas chromatography (20) (Table 2). Six groups of rats were 
fed ad libitum with 12 rats/diet for 10 weeks. Tap water was available ad 
libitum. Food consumption and body weight were measured weekly. After 
10 weeks of feeding, rats were fasted overnight and anesthetized with ether, 
blood was drawn from exposed jugular veins, and rats were killed by ether 
overdose. Eight milliliters of blood was drawn from exposed jugular veins 
into a syringe containing 1 ml acid citrate dextrose anticoagulant (4.5 g% 
sodium citrate, 2.7 g% citric acid (monohydrate) and 3.6 g% dextiose) for 
platelet preparation. Two milliliters of blood was drawn from exposed jugular 
veins for serum preparation. 
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Preparation of platelets 
Platelets were isolated from the uncoagulated blood by centrifugation 
using a modification of the procedure of Chan et al. (21). Blood samples from 
two animals in the same dietary group were pooled to obtain enough blood 
from which to prepare platelets. Blood was centrifuged at lOOx g for 15 min 
at room temperature, and the supernatant platelet rich plasma (PRP) was 
recentrifuged at 150x g for 15 min to remove contaminating red and white 
blood cells. Finally, the PRP was centrifuged at lOOOx g for 15 min to 
sediment the platelets. The platelet poor plasma (PPP) was removed, 1 ml of 
Dulbecco's phosphate buffered saline (PBS), 2.7 mM KCl, 1.5 mM KH2PO4, 
138 mM NaCl, 8.1 mM Na2HP04, pH 7.5, (Sigma Chemical Co., St. Louis, 
MO) was added, and the platelets were resuspended by gentle vortexing. The 
platelets were resedimented by centrifugation at lOOOx g for 15 min. The 
Dulbecco's PBS was discarded and 3 ml of fresh Dulbecco's PBS was added 
and, again, the platelets were resuspended by gentle vortexing. The purity of 
platelet suspensions was determined by Coulter Counter (Counter Electronics, 
Inc., Hialeah, FL). The purity was at least 95%. The platelet suspensions 
were stored at -SO^C. 
Aortic 6-keto-PGFi<v production 
Segments of aorta were removed carefully, cleaned of connective tissue 
and incubated in Dulbecco's PBS (pH 7.5) at 31^C for 30 min in a total 
volume of 1 ml. At the end of the incubation, aorta was removed, blotted on 
filter paper and weighed to obtain the "wet weight". The incubation media 
were stored at -SO^C for radioimmunoassay (RIA) which was done later. 
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Platelet fattv acid analyses 
Fatty acid analyses were performed by methods described by 
Krumhardt (20) and Morrison and Smith (22). Analyses were done under 
nitrogen. Fatty acid methyl esters were quantified by gas chromatography on 
a Varian 330 gas chromatograph (Walnut Creek, CA) equipped with a 3390A 
Hewlett Packard Integrator (Avondale, PA). An Alltech (Deerfield, IL) 
183x0.32 cm column loaded with a 10% 100/120 mesh Silan IOC stationary 
phase was used. Nitrogen carrier gas flow rate was 30 ml/min. Column 
temperature was ISO^C, injecdon port temperature was 220°C and flame 
ionization detector temperature was 2500C. Peaks were identified by 
comparison of retention times with those of authentic fatty acid methyl ester 
standards (Alltech, Deerfield, IL). The percentage of each fatty acid was 
determined by integration of peak areas. 
Vitamin E analysis 
Platelet «-tocopherol content was determined using a modification of 
the procedure of Catignani and Bieri (23). All samples were processed in a 
room illuminated by yellow light. One hundred microliter internal standard 
(a-tocopheryl acetate in ethanol, 62.2 mg/1) and 500 |il platelet suspension 
were mixed by vortexing for 1 min. HPLC grade hexane was added and 
mixed for another 1 min. Phases were separated by centrifugation at 2000 
rpm for 10 min. The hexane layer was withdrawn and evaporated under 
nitrogen. The residue was redissolved in 100 pi filtered HPLC grade 
methanol by mixing and 30 |il was injected. Chromatography was performed 
at ambient temperature. Reversed-phase HPLC was canied out on a Waters 
'Resolve" 5 \x Spherical CI8 column. The detector wavelength was 290 nm, 
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sensitivity 0.01 absorbance units full scale. Flow rate of 100% HPLC grade 
methanol was 1.5 ml/min and, recorder chai*t speed, 1 cm/min. Peak-area 
ratios of samples were converted to ng's a-tocopherol by a standard curve 
prepared with samples containing a constant amount of a-tococpherol acetate 
combined with different amounts of ot-tocopherol standai'd. 
Thromboxane B? and 6-keto-PGFirv assays 
Thromboxane B2 and ô-keto-PGFia levels were deteiTnined by double 
antibody radioimmunoassay as described by McCosh et al. (24) and Steinberg 
et al (25). 
The assays were performed over a 3-day period. On the first day, 
diluted primary antibody and diluted ARGG (1:1) were mixed and refrigerated 
at 40c overnight. Also, dilutions of NRS and ARGG (1:1) were mixed and 
refrigerated at 4^C overnight. The overnight incubation allo;ved binding of 
ARGG to the antibody. Rabbit antibodies to TXB2 and 6-keto-PGFia 
(primary antibodies) were gifts from Dr. Melvin M. Mathias at USDA/CSRS 
and Dr. Jacqueline Dupont at USDA/ARS, Washington, D. C. Primary 
antibodies were diluted to 1/400 in PBS-EDTA and further diluted to 1/1500 
for TXB2 and 1/3000 for 6-keto-PGFia with 1/400 NRS to give 30% binding 
to 3H-labeled TXB2 and 6-keto-PGFia in the assay system and stored at 
-20®C. Anti-Rabbit Gamma Globulin (ARGG) (goat) (secondaiy antibody) 
was purchased from Western Chemical Reseai'ch Coip., Fort Collins, CO; and 
was diluted to 1/60 with PBS-EDTA to give 30% binding to ^H-labeled TXB2 
and 6-keto-PGFia in the assay system and stored at -200C. PBS-EDTA was 
1.8612 g % Na2EDTA in PBS and adjusted to pH 7 with NaOH. Phosphate 
buffered saline (0.01 M) contained 0.82 g % NaCl, 0.0394 g % 
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NaH2P04.H20, 0.185 g % Na2HP04.7H20, and 0.00952 g % ethyl 
mercurithiosalicyclic acid (sodium salt) and was adjusted to pH 7 with HCl. 
Normal Rabbit Serum (NRS) was obtained from unimmunized rabbits and 
used to determine background binding of ^H-labeled TXB2 and 6-keto-PGFia 
in the assay system. NRS was diluted to 1/400 in PBS-EDTA for use. 
On the second day, samples were diluted 1/50 with PBS-gel which 
contained O.I g % Knox gelatin in PBS, and pipetted into 4 ml polypropylene 
tubes. One milliliter reaction mixture containing 200 |il platelet suspension 
(diluted 1/50 in PBS-gel), 300 |Lil PBS-gel, 400 |al Ab: ARGG, and 100 ill 3H-
TXB2 or 3H6-keto-PGFia were incubated overnight at 4^0. Labeled ^H-
TXB2 (specific activity 110.6 Ci/mmol) and 3H-6-keto-PGFia (specific 
activity 151 Ci/mmol) were obtained from New England Nuclear Corp., 
Boston, MA and stored at -SO^C. Tubes for background binding contained 
500 111 PBS-gel, 400 |xl NRS:ARGG, and 100 |li1 3H-TXB2 or 3H-6-keto-
PGFia. Total binding tubes contained 500 |il PBS-gel, 400 |il Ab:ARGG, and 
100 |J,1 3H-TXB2 or 3H-6-keto-PGFioc. 3H-TXB2 and -^H-ô-keto-PGFioc were 
diluted with PBS-gel to give approximately 10,000 counts per min (cpm) in a 
100 jil aliquot. One hundred |xl 3H-TXB2 or 3H-6-keto-PGFia was added to 
total count tubes to determine total counts per min added to each tube. All 
samples were run in duplicate. All background and total count determinations 
were done in triplicate, and total binding determinations were done with six 
replicates. A standard curve was prepared and mn along with the samples. 
Duplicates were run with one set of standards at the beginning of the sample 
run and one set at the end. Means of measurements were used to calculate the 
concentration of samples. Standard TXB2 and 6-keto-PGFia were gifts from 
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Upjohn (Kalamazoo MI), stored at -20OC in ethanol (2 |ig/ml) and diluted to 
20 ng/ml in PBS-gel for use. Components used to determine the standard 
curve are shown in Table 3. All tubes were covered with parafilm, gently 
mixed in racks, and refrigerated overnight. 
On the third day, 3 ml of PBS was added to all tubes except the total 
count tubes. All tubes except the total count tubes were centrifuged at 3000 
rpm for 30 min (Beckman J-6B centrifuge, JR-3.2 rotor). The supernatant was 
poured off and the tubes were blotted on absorbent paper. To each tube, 
including the total count tubes, 0.3 ml water and 3.5 ml Scintiverse BD 
(Fisher) were added. Tubes were capped and vortexed until clear. 
Radioactivity as cpm was determined using a Beta Trac Liquid Scintillation 
Counter (Model 6895) (TM Analytic Inc., Elk Grove Village, IL), counting 
for either 10 min or until 10,000 counts were measured. 
The assay was based on competition between 3H-labeled prostaglandin 
and cold prostaglandin for binding sites on antibody. ARGG served to 
precipitate the antibody so that it was pelleted by the centrifugation step. 
When more standard prostaglandin or sample prostaglandin was present, less 
^H-labeled prostaglandin was bound, and vice versa. A computer program 
developed by Duddleson et al. (26) was used to detennine the prostaglandin 
concentration by comparison with the standai'd curve. 
Lipid peroxidation analysis 
Platelet lipid peroxidation was measured by assaying thiobaibituric 
acid-reactive substances (TBARS) using a modification of the procedure 
described by Fraga et al. (27). Platelet suspension was incubated with 1 mM 
t-butyl hydroperoxide (t-BuOOH) for 30 min. To the incubation mixture, 0.5 
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ml of 3% sodium dodecyl sulfate was added. After mixing, 2 ml of 0.1 N 
HQ, 0.3 ml of 10% phosphotungstic acid, and 1 ml of 0.7% 2-thiobarbituric 
acid were added. The mixture was then heated for 30 min in boiling water, 
followed by TEARS extraction into 5 ml 1-butanol. After centrifugation, the 
fluorescence of the butanol layer was measured at 515 nm excitation and 555 
nm emission, in a Fluorolog 2 spectrometer (Spex Industries, Inc., Metuchen, 
NJ). The values were expressed as nanomoles of TEARS per mg of protein. 
Malondialdehyde standard curve was prepared by using 1,1,3,3-
tetramethoxypropane. 
Platelet phospholipase A2 activity assay 
Platelet phospholipase A2 activity was measured by a modification of 
the procedure of Steinbrecher and Pritchard (28). Platelet suspension was 
incubated with 25 nmol of substrate (1-palmitoyl 2-[12-(13-
nitrobenzoxadiazolyl)-amino]caproyI phosphatidylcholine (C^NBD PC) in 3 
ml Dulbecco's PBS containing 50 mM taurocholic acid, 20 mM calcium 
chloride, and 0.05 g% fatty acid free bovine serum albumin at 37^0 for 40 
min. Taurocholic acid was used as a biological amphipath in the assay to aid 
in access of PLA2 enzyme to the substrate. The concentration used was the 
same as found in human serum by Dupont et al. (29). Reactions were stopped 
by the addition of 1.2 ml methanol and 1.2 ml chlorofomi followed by mixing 
for 1 min. The mixtures were centrifuged at 2000 g for 15 min to separate the 
phases and the fluorescence of the aqueous layer was measured with a 
Fluorolog 2 Spectiometer (Spex Industries, Inc., Metuchen, NJ) at 470 nm 
excitation and 533 nm emission. The mass of fluorescent substrate 
hydrolyzed was determined by comparison with a standard curve generated by 
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serial dilutions of 6(7-nitrobenzoxadiazolyl) aminocaproic acid (Avanti Polar 
Lipids, Birmingham, AL). 
Protein analysis 
Protein was measured by the method of Lowry et al. (30) using bovine 
serum albumin as the standard. 
Statistical analysis 
All analyses were done in duplicate for each sample. Data were 
analyzed by using General Linear Model (SAS Institute, Caiy, NC). Least 
Square Difference of the Statistical Analysis System (SAS Institute, Gary, 
NC) was used to test the significance between means of treatments. Two-way 
ANOVA analysis was used to determine the interaction between increasing 
dietary linoleate and vitamin E supplementation. Peaison correlation 
coefficients also were calculated. A p<0.05 was taken to be statistically 
significant. 
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RESULTS 
Animals and diets 
There was no difference in food intake, liver weight or body weight 
gain of rats fed 11 or 18 en% linoleate (Fig. 1). The liver weight as a 
percentage of body weight was not different due to en% linoleate (Fig. 2). 
There was no difference in food intake and body weight gain of rats fed 0,100 
or 5000 ppm vitamin E, however, liver weight was significantly greater in the 
group fed 5000 ppm vitamin E than in the group fed 100 ppm vitamin E 
(10.4±0.8 vs 9.7+0.7 g) (Fig. 3). The liver weight as a percentage of body 
weight was significantly greater in the 5000 ppm vitamin E group than in the 
100 ppm vitamin E group (2.610.1 vs 2.5±0.1%) (Fig. 4). 
Platelet fattv acid composition 
There was no difference in platelet fatty acids, C12:0, C14:0, C16:0, 
CI8:0, C20:ln-9 and C20:4n-6, in rats fed different levels of en% linoleate 
(Fig. 5). But platelet C18:ln-9 (oleic acid) was significantly greater in the 11 
en% linoleate group (4.8+1.2 vs 3.3+1.7%) and C18:2n-6 (linoleic acid) was 
significantly greater in the 18 en% linoleate group (7.8+2.3 vs 4.7+1.2%) (Fig. 
5). There was no difference in platelet fatty acids, C12:0, C14:0, C16:0, 
C18:0, C18:ln-9, C18:2n-6 and C20:ln-9, in rats fed different levels of 
vitamin E (Fig. 6). However, platelet C20:4n-6 (arachidonic acid) was 
significantly greater in the vitamin E-deficient group than in the 5000 ppm 
vitamin E group (28.4+4.6 vs 23.8+6.3%) (Fig. 6). Platelet C18:0 (stearic 
acid) was decreased with increasing vitamin E supplementation in the 11 en% 
linoleate group, but it was increased with 5000 ppm vitamin E 
supplementation in the 18 en% linoleate group (Fig. 7). There was an 
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interaction of increasing dietary linoleate and vitamin E supplementation on 
platelet CI8:0 fatty acid. 
Platelet vitamin E level 
Effects of increasing dietary linoleate on platelet vitamin E 
concentration was examined. There was no difference in platelet vitamin E of 
rats fed 11 or 18 en% linoleate (Fig. 8). There were significant differences in 
platelet vitamin E of rats fed 0, 100 or 5000 ppm vitamin E (0.2+0.4, 2.7±0.7, 
4.2+1.0 ng/|j.g protein, respectively) (Fig. 9). 
Prostaglandins 
There were no differences in serum TXB2, 6-keto-PGFia and aortic 6-
keto-PGFioc concentrations of rats fed 11 or 18 en% linoleate (Fig. 10). The 
serum TXB2/6-keto-PGFia ratio of rats fed 11 or 18 en% linoelate also did 
not differ (Fig. 11). There was no difference in serum and aortic 6-keto-
PGFia concentrations due to vitamin E supplementation (Fig. 12). But, 100 
or 5000 ppm vitamin E significantly reduced serum TXB2 production 
compared with rats receiving no vitamin E (215.5+71.1, 170.5+66.4, 
399.6+108.9 ng/ml, respectively) (Fig. 12). The serum TXB2/6-keto-PGFia 
ratio of rats was significantly greater in the vitamin E-deficient group than in 
the 5000 ppm vitamin E group (49.7± 13.4 vs 35.1±17.2) (Fig. 13). 
Platelet lipid peroxidation 
Platelet lipid peroxidation was measured by assaying t-BuOOH-induced 
TBARS. Platelet TBARS were not significantly different between rats fed 11 
or 18 en% linoleate (5.1±0.6 vs 5.4dh0.8 pmol/p,g protein) (Fig. 14). Rats fed 
no vitamin E had significantly greater platelet TBARS than rats fed 100 or 
5000 ppm vitamin E (5.9+0.7, 5.0+0.4, 4.7+0.2 pmol/|Lig protein, respectively) 
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(Fig. 15). 
Platelet phospholipase activity 
Platelet phospholipase A2 activity did not differ with increasing dietary 
linoleate or vitamin E status (Fig. 16,17). 
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DISCUSSION 
Mcintosh et al. (31) investigated the effect of vitamin E deficiency on 
platelet function and prostaglandin production in marmoset monkeys and 
found during their 9 month study that vitamin E deficiency reduced body 
weight gain and resulted in lower skeletal muscle weights. Vitamin E 
deficiency did not affect weight gain in our study which could be due to the 
difference in animal species or feeding period (Fig. 3). The length of our 
study, 2.5 months, probably was not long enough to cause myopathies and 
decrease muscle weights (29), therefore, differences in body weight gain were 
not found. Rice and Kennedy (32) showed that vitamin E deficiency would 
lead to skeletal and cardiac myopathies in a variety of animals and poultry. 
They also indicated that vitamin E deficiency can cause hepatic necrosis, 
telangiectasis and lipoid degeneration which could lead to lower liver weights. 
Mean liver weight of rats fed 5000 ppm vitamin E in our study was 
significantly greater than the mean liver weight of rats fed 100 ppm vitamin E 
(Fig. 3). However, a diet containing 100 ppm vitamin E is adequate for rats. 
The mechanism for reduced liver weight in the group receiving 100 ppm 
vitamin E compared with the group fed 5000 ppm vitamin E is unknown. 
The changes in platelet fatty acid composition, increasing 18:2n-6 with 
increasing dietary linoleate (Fig 5), were consistent with results of Piche and 
Mahadevappa (33) and Iritani and Naiita (34). Platelet aiachidonic acid level 
wasgreatest in the vitamin E-deficient group (Fig. 6). This suggests that 
vitamin E or oxidative stress may have a role in fatty acid desaturation and 
elongation. Mcintosh et al. (31) observed that vitamin E increased or 
decreased platelet phospholipid arachidonic acid depending on dietary 
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treatments. In a basal diet which supplied 1.2% (w/w) sunflower seed oil, 
vitamin E supplementation decreased platelet phospholipid arachidonic acid. 
But, after increasing sunflower seed oil to 10% (w/w), vitamin E 
supplementation increased platelet phospholipid arachidonic acid. The role of 
vitamin E in fatty acid desaturation and elongation needs further study. 
The measurement of platelet vitamin E was chosen to reflect dietary 
vitamin E intake based on the suggestion of Lehmann (35) who showed that 
platelet vitamin E was more sensitive than red blood cell or plasma in 
reflecting vitamin E intake. The amount of vitamin E required to prevent lipid 
peroxidation can depend on the dietary intake of fat, particulaiiy the intake of 
polyunsaturated fatty acids (36). In this study, linoleate contributed 11 and 18 
en%. Even though there were differences in platelet linoleate (Fig. 5), platelet 
vitamin E concentration (Fig. 8) was not altered by dietary linoleate. Chan et 
al. (37) indicated that the retention of tocopherol by rat platelets appeared to 
be logarithmatically related to increasing vitamin E concentration in the diets. 
Results in this study (Fig. 9) tended to be logaiithmadc in agreement with the 
experiment of Chan et al. 
Effects of dietary fat on prostaglandin biosynthesis have been studied 
by Dupont et al. (17), Sullivan and Mathias (18) and Mathias and Dupont 
(38). In these studies, 2 en% linoleate was found to be optimal for 
prostaglandin production. Greater en% linoleate was not coiTelated with 
greater prostaglandin production and varying the dietai'y P/S ratios has also 
been found to affect prostaglandin synthesis (38). Dietary P/S ratios between 
0.4 and 5.5 did not significantly affect serum prostaglandin levels while a 
dietary P/S ratio of 9 was found to increase semm prostaglandin levels 
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markedly (39). The proportion of total energy supplied by linoleate in the 
present study was 11 and 18% and the dietary P/S ratios of 1.6 and 5.4 were 
well within the ranges previously described (39) not to affect prostaglandin 
status. Neither change in en% linoleate nor P/S ratio caused change in 
prostaglandin status (Fig. 10). These results were consistent with observations 
of other laboratories (17,18,38,39). 
Studies on the effect of dietary vitamin E on prostaglandin synthesis 
have not been consistent. In several species, vitamin E supplementation has 
been demonstrated to depress platelet TXA2 synthesis and usually to enhance 
aortic PGI2 synthesis (2,11,12). However, Stampfer et al. (9) found no effect 
of vitamin E on TXA2 production or PGI2 production. Swai'tz et al. (10) have 
reported decreased plasma PGI2 levels in healthy adult subjects supplemented 
with vitamin E. Falanga et ai. (40) indicated increased serum PGI2 in vitamin 
E deficient rats. In the present study, vitamin E did not affect prostacyclin 
synthesis (Fig. 12). These results were in agreement with the work of 
Stampfer et al. (9). Thromboxane A2 production, measured as TXB2, was 
inhibited by vitamin E adequacy and supplementation in this study (Fig. 12). 
These results support the work of Kaipen et al. (11 ). Contradictory results 
obtained by different laboratories could be due to different vitamin E dosages 
used in the ranges of 0 to 1000 mg/kg diet, differences in feeding period from 
8 to 23 weeks, species variation, for example rats, rabbits and humans and 
different techniques of tissue sampling and prepai'ation. 
TXA2 is a platelet aggregator and vasoconstrictor, and PGI2 is a platelet 
antiaggregator and vasodilator. The balance between TXA2 and PGI2 is 
important, because platelet aggregation and vasoconstriction may precipitate 
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acute atherosclerotic incidents such as infarcts. An altered balance of 
TXA2/PGI2 in streptozotocin-induced diabetic rats was reported by Karpen et 
al. (41). TXA2/PGI2 balance was restored to normal when diabetic rats were 
supplemented with vitamin E (3). The serum TXA2/PGI2 ratio of rats in the 
present study was significantly greater in the vitamin E-deficient group 
compared with the ratio of rats in the 5000 ppm vitamin E group (Fig. 13). 
Therefore, results of the present study indicate that vitamin E supplementation 
may have an antithrombotic effect or that vitamin E deficiency is 
prothrombogenic. 
There was a significant correlation between platelet TXB2 and t-
BuOOH-induced TEARS (r=0.66, p<0.0001). This suggests that increased 
lipid peroxidation due to vitamin E deficiency can stimulate TXB2 synthesis. 
However, vitamin E supplementation did not inhibit TXB2 synthesis 
compared with vitamin E adequacy. (Fig. 12). It is known that oxidative 
stress can cause lipid peroxidation (42). Other conditions associated with 
oxidative stress, such as dietary copper deficiency can increase hepatic PGE2 
and PGF2a production (43) and depress aortic PGI2 synthesis rates (44) and 
both of these changes were associated with reduced superoxide dismutase 
(SOD) activity which is one of the major intracellular antioxidant defenses of 
mammalian cells (45). Reduced SOD activity implies increased oxidative 
stress. Oxidative stress, such as occurs in vitamin E deficiency, might 
increase synthesis of TXB2, it may just as enhance PGE2 and PGF2a 
production (43,46,47). The effect of vitamin E deficiency on TXA2 
production may be mediated by oxidative stress which has been shown to 
stimulate production of other PGs as well (50). In the present study, vitamin 
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E supplementation did not affect PGI2 status (Fig. 12). The effects of vitamin 
E on TXA2 and PGI2 production differ, and TXA2 and PGI2 do not seem to 
respond in the same way during oxidative stress because increased TXA2 
synthesis during oxidative stress but no alteration in PGI2 synthesis during 
oxidative stress. The mechanisms of oxidative stress-induced PG production 
are not understood. 
Vitamin E did not show an effect on endogenous platelet phospholipase 
A2 activity in the present study (Fig. 17), although vitamin E supplementation 
is suggested to inhibit phospholipase A2 activity (1). The mechanism by 
which vitamin E may influence platelet phospholipase activity is not clear. 
Sulfhydryl cross-linking with the oxidizing agent diazenedicai'boxylic 
acid(bis)dimethylamide enhanced arachidonic acid release from platelet 
membranes (48) and lipid peroxides could enhance sulfhydryl cross-linking. 
Furthermore, Yasuda and Fujita (49) showed that lipid peroxidation enhanced 
fatty acid release from mitochondria. Since vitamin E inhibits lipid 
peroxidation, this inhibition could diminish the sulfhydryl cross-linking that 
promotes phospholipase A2 activity. Because vitamin E deficiency only 
stimulated lipid peroxidation when an oxidative stressor, t-BuOOH, was 
introduced, perhaps only more extreme oxidative stiess than vitamin E 
deficiency activates phospholipase A2. 
Results from platelet lipid peroxidation measurements support the role 
of vitamin E as an antioxidant which inhibits peroxidation of lipids containing 
polyunsaturated fatty acids (PUFA). Krumhardt (20) has shown that en% 
linoleate greater than 4.5 can inhibit platelet phospholipase A2 activity. There 
was no difference in phospholipase À2 activity of rats fed 11 or 18 en% 
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linoleate (Fig. 16). The en% linoleate in this study was different from that of 
Krumhardt who fed 3.0,4.5, 6.0, 7.5 or 9.0 en% linoleate, making it difficult 
to compare the effect of en% linoleate on phospholipase A2 activity. Tangney 
and Driskell (50) demonstrated that vitamin E inhibited platelet phospholipase 
A2 activity. They found an enhancement of thrombin-induced phospholipase 
A2 activity in platelets of vitamin E deficient rabbits that had been deprived of 
vitamin E for 7 months. Perhaps the present results showing no effect of 
vitamin E status on PLA2 activity (Fig. 17) differed from those of Tangney 
and Driskell (50) because of the absence of thrombin-induction. 
C18:2n-6 was negatively correlated with C20:4n-6 in platelets (r=-0.37, 
p<0.05), and this finding was in agreement with Spector et al. (14,15). These 
authors demonstrated an increase in the percentage of C18:2n-6 associated 
with a decrease in C20:4n-6 in the phospholipid fraction. This suggests that 
high concentrations of linoleate reduce the incoiporation of ai'achidonic acid 
into cellular phospholipids. C18:2n-6 was negatively con-elated with 
phospholipase A2 activity (r=-0.41, p<0.05). An inhibitory effect of 
unsaturated fatty acids on phospholipase A2 activity was shown by Ballou and 
Cheung (16). In the present study, because C20:4n-6 was positively 
correlated with TXB2 concentration (r=0.34, p<0.05), an increased 
arachidonic acid pool may be necessary for increased TXB2 production. That 
vitamin E deficiency causes lipid peroxidation was demonstrated in the 
present study (Fig. 15). Elevated C20:4n-6 was also associated with increased 
TEARS (r=0.44, p<0.02). Increased arachidonate may have pennitted the 
increased TX production in vitamin E deficiency. In some way, vitamin E 
deficiency causes greater C20:4n-6 (aiachidonate) and increased TXA2, but 
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not PGI2 status. Perhaps, other oxidative stressors can also stimulate PG 
production by increasing arachidonate. How oxidative stress might increase 
tissue arachidonate is unclear. 
The present study suggests that oxidative stress produced by vitamin E 
deficiency can be prothrombogenic by virtue of its stimulatory effect on 
TXA2 synthesis. Although the mechanism is unknown, perhaps it is mediated 
by an effect on the PG precursor, arachidonate. 
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Table 1. Composition of experimental diets 
Energy Percentage 
Linoleate^ 
Ingredient 11 18 
• g/lOOg 
Lard, tocopherol-strippedb 7.2 • " • 
Com Oil, tocopherol-stripped^ 7.2 14.3 
Casein "Vitamin Free" Test^» 22.4 22.4 
Sucrose^ 26.4 26.4 
Com Starch^ 26.4 26.4 
Cellulose^ 5.0 5.0 
AIN Mineral Mixture 76^0 3.9 3.9 
Vitamin Mixture (a-tocopherol 1.1 1.1 
devoid)bd 
Tocopheryl Acetate^ o
 
o
 
b
 
0.5 0, 0.01, 0.5 
L-Methionine^ 0.3 0.3 
Choline Chloride^^ 0.08 0.08 
Ascorbic Acid (antioxidant)b 0.01 0.01 
Cholesterol (mg/100 g)t> 0 6.8 
^Each level of linoleate was fed with 0, 100 or 5000 ppm a-tocopheryl 
acetate. 
bTeklad, Madison, WI. 
^Composition described by the AIN Ad Hoc Committee on Standards for 
Nutritional Studies, 1977 (19). 
^Composition described by the AIN Ad Hoc Committee on Standards for 
Nutritional Studies, 1977 (19), except that vitamin E acetate was substituted 
by sucrose. 
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Table 2. Fatty acids composition of experimental diets 
11 en% linoleate 18 en% linoleate 
% 
14 1.0 — 
15 0.1 
16 18.1 10.2 
16:1 2.1 ' 
18 5.5 1.8 
18:1 33.8 23.9 
18:2 37.5 62.0 
18:3 1.1 2.1 
20:1 0.6 
20:2 0.2 
P/S ratio 1.6 5.4 
P/M ratio 1.1 2.7 
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Table 3. Preparation of standard curve for TXB2 and 6-keto-PGFia 
Standard (20 ng 3ii-TXB2 or 
Tube No. PBS-Gel /ml) TXB2 or 6- AbiARGG 3H.6-keto-
keto-PGFia PGFig 
1 0 500.0 400 100 
2 250.0 250.0 400 100 
3 375.0 125.0 400 100 
4 437.5 62.5 400 100 
5 468.8 31.2 400 100 
6 484.4 15.6 400 100 
7 492.2 7.8 400 100 
8 496.1 3.9 400 100 
9 498.0 2.0 400 100 
10 499.0 1.0 400 100 
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2 18en%Lin 
11 en% Lin 
Liver Wt Bd Wt Gain Food Intake 
Figure 1. Effect of en% linoleate on liver weight, body weight gain and food 
intake. Groups that do not shai'e the same letter ai'e significantly 
different from one another, p<0.05 
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2 18en%Lin 
11 en% Lin 
C) 
W) 
i 
o k 0) 
CU 
1 -
0 - ^  
a 
Liver Wt/BW 
Figure 2. Effect of en% linoleate on liver weight as percentage of body 
weight. Groups that do not share the same letter aie significantly 
different from one another, p<0.05 
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1 6  
3 Vit E 0 ppm 
VitE 100 ppm 
Vit E 5000 ppm 
— 
Liver Wt Bd Wt Gain Food Intake 
Figure 3. Effect of vitamin E status on liver weight, body weight gain and 
food intake. Groups that do not share the same letter ai'e 
significantly different from one another, p<0.05 
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Liver Wt/BW 
Figure 4. Effect of vitamin E status on liver weight as percentage of body 
weight. Groups that do not share the same letter ai-e significantly 
different from one another, p<0.05 
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12:0 14:0 16:0 18:0 18:1 18:2 20:1 20:4 
Figure 5. Effect of en% linoleate on platelet fatty acid composition. Groups 
that do not share the same letter are significantly different from one 
another, p<0.05 
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Figure 6. Effect of vitamin E status on platelet fatty acid composition. 
Groups that do not share the same letter aie significantly different 
from one another, p<0.05 
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• 18 en% Lin+Vit E 0 ppm 
1 18 en% Lin+Vit E 100 ppm 
18 en% Lin+Vit E 5000 ppm 
• 11 en% Lin+Vit E 0 ppm 
s 11 en% Lin+Vit E 100 ppm 
0 11 en% Lin+Vit E 5000 ppm 
18:0 
Figure 7. Interaction of en% linoleate and vitamin E status on platelet CI8:0. 
Groups that do not shaie the same letter ai'e significantly different, 
p<0.05 
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Figure 8. Effect of en% linoleate on platelet vitamin E level. Groups that do 
not share the same letter are significantly different from one 
another, p<0.05 
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Figure 9. Effect of vitamin E supplementation on platelet vitamin E level. 
Groups that do not share the same letter are significantly different 
from one another, p<0.05 
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Figure 10. Effect of en% linoleate on prostaglandin status. Groups that do 
not share the same letter are significantly different from one 
another, p<0.05 
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Figure 11. Effect of en% linoleate on serum TXB2/6-keto-PGFia (TX/PG) 
ratio. Groups that do not share the same letter ai-e significantly 
different from one another, p<0.05 
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Figure 12. Effect of vitamin E status on prostaglandin status. Groups that do 
not share the same letter aie significantly different from one 
another, p<0.05 
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Figure 13. Effect of vitamin E status on serum TXB2/6-keto-PGFia (TX/PG) 
ratio. Groups that do not shai'e the same letter are significantly 
different from one another, p<0.05 
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Figure 14. Effect of en% linoleate on t-BuOOH-generated platelet lipid 
peroxidation (as measuring thiobarbituric acid reactive substance). 
Groups that do not shaie the same letter ai'e significantly different 
from one another, p<0.05 
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Figure 15. Effect of vitamin E status on t-BuOOH-generated platelet lipid 
peroxidation (as measuring thiobai-bituric acid reactive substance). 
Groups that do not share the same letter aie significantly different 
from one another, p<0.05 
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Figure 16. Effect of en% linoleate on platelet phospholipase A] activity 
(PLA2). nmole 6(7-nitrobenzoxadiazolyl) aminocaproic acid 
released from 1-palmitoyl 2-[12-(13-nitrobenzoxadiazolyl)-aniino] 
caproyl phosphatidylcholine in 40 min per |ig platelet protein. 
Groups that do not share the same letter aie significantly different 
from one another, p<0.05 
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Figure 17. Effect of vitamin E status on platelet phospholipase A2 activity 
(PLA2). nmole 6(7-nitrobenzoxadiazolyl) aminocaproic acid 
released from 1-palmitoyl 2-[12-(13-nitrobenzoxadiazoly])-amino] 
caproyl phosphatidylcholine in 40 min per |ig platelet protein. 
Groups that do not shaie the same letter ai'e significantly different 
from one another, p<0.05 
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PAPER II. INFLUENCE OF INCREASING DIETARY LINOLEATE 
AND VITAMIN E SUPPLEMENT ON SERUM LIPID 
LEVELS IN MALE SPRAGUE-DAWLEY RATS 
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ABSTRACT 
The present study was conducted to determine whether increasing 
dietary linoleate and vitamin E supplementation interact to lower serum lipid 
levels. We hypothesized that increasing dietary linoleate could decrease 
serum lipid levels (e.g., total cholesterol, LDL-cholesterol and tiiglyceride) 
and vitamin E supplementation could increase serum HDL-cholesterol level. 
The influence of increasing dietary linoleate and d,l-a-tocopheryl acetate 
(vitamin E) supplementation on serum triglyceride, total, high-density 
lipoprotein (HDL) and low-density lipoprotein (LDL) cholesterol was studied 
in 72 weanling male Sprague-Dawley rats. Rats were fed semipurified diets 
containing 11 or 18% of energy (en%) from linoleate and graded levels (0, 
100 or 5000 ppm) of vitamin E for 10 weeks. Vitamin E status was confirmed 
by serum vitamin E level. Rats fed no vitamin E had the lowest serum 
vitamin E and rats fed 5000 ppm vitamin E had the greatest serum vitamin E 
(p<0.05). Lipid status was verified by platelet fatty acid composition. Platelet 
C18:ln-9 (oleic acid) was significantly greater in the 11 en% linoleate group 
than in the 18 en% linoleate group, and platelet C18:2n-6 (linoleic acid) was 
significantly greater in the 18 en% linoleate group than in the 11 en% linoleate 
group (p<0.05). The treatments had no effect on food intake, body weight 
gain, serum total cholesterol and LDL-cholesterol levels. Serum triglyceride 
level was significantly greater in the group fed 11 en% linoleate than in the 
group fed 18 en% linoleate (p<0.05). Serum HDL-cholesterol concentration 
was significantly less in the vitamin E-deficient group than in the other two 
groups (p<0.05). The results indicate that semm triglyceride levels are 
sensitive to dietary linoleate manipulation while HDL-cholesterol is sensitive 
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to vitamin E status. Prevention of vitamin E deficiency, but not vitamin E 
supplementation, seems to alter serum lipids in a manner which may protect 
from atherosclerosis. 
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INTRODUCTION 
Elevated plasma cholesterol is well established as a factor in the 
development of atherosclerosis. Clinical trials have shown that reduced total 
plasma cholesterol is associated with reduced coronaiy heart disease in 
human, and that a 1 % reduction in plasma cholesterol may result in a 2% 
reduction in coronary heart disease (CHD) (1,2). Brown and Goldstein (3) 
and Mahley and Innerarity (4) have shown that cholesterol homeostasis is 
closely related to plasma lipoprotein metabolism. Plasma HDL-cholesterol 
has an inverse relation with the risk of (CHD) (5,6). There is persuasive 
evidence that this protective association is causal because the role of HDL is 
to transport cholesterol from peripheral tissues to the liver where it is 
catabolized and excreted. In contrast, the role of LDL is to transport 
cholesterol from liver to peripheral tissues and regulate de novo cholesterol 
synthesis at these sites. Therefore, there is great interest in factors that alter 
the composition and concentrations of these lipoproteins. 
Serum tocopherol is carried primarily by the lipoproteins (7,8,9). 
Studies of the relationships between vitamin E and cholesterol distribution and 
concentration in plasma lipoproteins give equivocal data. Sundai'am et al. (7) 
studied 26 patients who received 600 mg a-tocopherol per day for 21 days. 
Serum samples were collected before and after the treatment and HDL-
cholesterol increased and LDL-cholesterol decreased due to the therapy. 
Chupukcharoen et al. (10) determined the effect of vitamin E deficiency on 
lipoprotein cholesterol distribution. An increase in plasma cholesterol was 
detected in LDL and VLDL, but not in the HDL fraction of the plasma 
lipoproteins. However, Hatam and Kay den (11) studied 11 subjects 
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supplemented with 800 mg of vitamin E daily. Although the serum 
cholesterol concentration did vary slightly in some subjects, the percentage of 
cholesterol in the HDL fraction was not significantly altered. The mechanism 
of vitamin E effect on serum cholesterol distribution is not clear. Perhaps, 
oxidative stress could increase serum choleterol level and suppression of 
oxidative stress could decrease serum choleterol level. Vitamin E deficiency 
is known to induce oxidative stress (12). Copper deficiency can cause 
oxidative stress (13,14) and increase plasma cholesterol level in rats (15). 
Other oxidative stressors (e.g., polychlorinated biphenyls (PCB) and 
phénobarbital) were found to increase serum cholesterol level (16). It seems 
that vitamin E affects serum cholesterol level via its role in oxidative sti'ess. 
It is well established that polyunsaturated fatty acids have a 
hypocholesterolemic action in humans and animals. Ibrahim and McNamara 
(17) conducted a study in guinea pigs to investigate the effects of saturated fat 
(lard) and unsaturated fat (corn oil) on plasma cholesterol level when diets 
supplied 20 en% as fat. In comparison to the lard diet, the corn oil diet 
resulted in a 34% reduction in plasma total cholesterol level (p<0.02) and a 
40% lower triacylglycerol level (p<0.02). Also, feeding the corn oil decreased 
the percent cholesterol ester in both LDL and VLDL. The results of this study 
were consistent with that of Shepherd et al. (18) who deteiTnined the effects of 
saturated and polyunsaturated fats on the chemical composition of lipoproteins 
in eight normal male subjects. The fats supplied 40% energy. The 
polyunsaturated fat lowered both plasma cholesterol (23%, p<0.0001) and 
triglyceride (14%, p<0.0001) levels. 
The present study reports the involvement and interactions between 
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increasing dietary linoleate and vitamin E status in regulating serum lipid 
levels. We hypothesized that increasing dietary linoleate could decrease 
serum lipid levels (e.g., total cholesterol, LDL-cholesterol and triglyceride) 
and vitamin E supplementation could increase HDL-cholesterol level. Dietary 
linoleate supplied either 11 or 18 en% and vitamin E levels are 0,100 or 5000 
ppm. Diets were fed to rats for 10 weeks and serum lipids measured and 
correlated with serum vitamin E level. 
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MATERIALS AND METHODS 
Animals and diets 
Seventy-two weanling male Sprague-Dawley rats (Harlan Sprague-
Dawley, Indianapolis, IN) weighing 50-60 g were individually housed in 
stainless cages on a 12-h light-dark cycle. The room was maintained at 22 
and approximately 50% humidity. Rats were randomly assigned to 
experimental diets in a randomized block experimental design, and the blocks 
represented the days when the rats were sacrificed and samples were 
processed. 
The experimental diets were nutritionally complete and supplied 30% of 
energy (en%) as fat (Table 1). Diets supplied 0, 100 or 5000 mg d,l-a-
tocopheryl acetate/kg of diet. Dietary fat was composed of different 
proportions of tocopherol-stripped com oil and tocopherol-stiipped lard to 
provide 11 or 18 en% linoleate, with cholesterol added as required to provide 
equal amount of cholesterol in all diets. Fatty acid composition of fat sources 
was analyzed by gas chromatography (20) (Table 2). Six groups of rats were 
fed ad libitum with 12 rats/diet for 10 weeks. Tap water was available ad 
libitum. Food consumption and body weight were measured weekly. After 
10 weeks of feeding, rats were fasted overnight and anesthetized with ether, 
blood was drawn from exposed jugular veins, and then rats were killed by 
ether overdose. Eight milliliters of blood was drawn from exposed jugular 
veins into a syringe containing 1 ml acid citrate dextrose anticoagulant (4.5 
g% sodium citrate, 2.7 g% citric acid (monohydrate) and 3.6 g% dextrose) for 
platelet preparation. Two milliliters of blood was drawn from exposed jugular 
veins for serum preparation. 
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Preparation of platelets 
Platelets were isolated from the uncoagulated blood by centrifugation 
using a modification of the procedure of Chan et al. (21). Blood samples from 
two animals in the same dietary group were pooled to obtain enough blood 
from which to prepare platelets. Blood was first centrifuged at lOOx g for 15 
min at room temperature, and then the supernatant platelet rich plasma (PRP) 
was recentrifuged at 150x g for 15 min to remove contaminating red and white 
blood cells. Finally, the PRP was centrifuged at lOOOx g for 15 min to 
sediment the platelets. The platelet poor plasma (PPP) was removed, 1 ml of 
Dulbecco's phosphate buffered saline (PBS), 2.7 mM KCl, 1.5 mM KH2PO4, 
138 mM NaCl, 8.1 mM Na2HP04, pH 7.5, (Sigma Chemical Co., St. Louis, 
MO) was added, and the platelets were resuspended by gentle vortexing. The 
platelets were resedimented by centrifugation at lOOOx g for 15 min. The 
Dulbecco's PBS was discarded and 3 ml of fresh Dulbecco's PBS was added 
and, again, the platelets were resuspended by gentle vortexing. The purity of 
platelet suspensions was determined by Coulter Counter (Counter Electronics, 
Inc., Hialeah, PL). The purity was at least 95%. The platelet suspensions 
were stored at -SO^C. 
Preparation of serum 
Following collection, blood samples from two animals in the same 
dietary group were pooled and allowed to clotted by incubadon for 1 hr at 
37°C. Serum was removed after centrifugation and stored at -BO^C. 
Platelet fattv acid analyses 
Fatty acid analyses were performed by methods described by 
Krumhardt (20) and Morrison and Smith (22). Analyses were done under 
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nitrogen. Fatty acid methyl esters were quantified by gas chromatography on 
a Varian 330 gas chromatograph (Walnut Creek, CA) equipped with a 3390A 
Hewlett Packard Integrator (Avondale, PA). An Alltech (Deeiiield, IL) 
183x0.32 cm column loaded with a 10% 100/120 mesh Silan IOC stationary 
phase was used. Nitrogen carrier gas flow rate was 30 ml/min. Column 
temperature was ISO^C, injection port temperature was 220OC and flame 
ionization detector temperature was 250OC. Peaks were identified by 
comparison of retention times with those of authentic fatty acid methyl ester 
standards (Alltech, Deerfield, IL). The percentage of each fatty acid was 
determined by integration of peak areas. 
Vitamin E analysis 
Serum a-tocopherol content was determined using a modification of the 
procedure of Catignani and Bieri (23). All samples were processed in a room 
illuminated by yellow light. Fifty |il of internal standai'd (a-tocopheryl acetate 
in ethanol, 59.6 mg/1) and 100 |li1 serum were mixed by vortexing for 1 min. 
For extraction of the lipid, 200 |il HPLC grade hexane was added and mixed 
for another 1 min. Phases were separated by centrifugation at 2000 rpm for 2 
min to separate phases. The hexane layer was withdrawn and evaporated 
under nitrogen. The residue was redissolved in 70 |al filtered HPLC grade 
methanol by mixing and thirty jil was injected. Chromatography was 
performed at ambient temperature. Reversed-phase HPLC was caiTied out on 
a 3.9 mm x 30 cm stainless steel packed with micro Bondapak C-18. The 
detector wavelength was 290 nm, sensitivity 0.01 absorbance units full scale. 
The solvent was HPLC grade methanol : water, 95 : 5, the flow rate was 2.0 
ml/min, and recorder chart speed, 1 cm/min. Peak-aiea ratios of samples were 
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converted to |Lig's a-tocopherol by a standard curve prepaied with samples 
containing a constant amount of a-tococpherol acetate combined with 
different amounts of a-tocopherol standard. The least amount of a-tocopherol 
can be detected in serum is 4 |ig/ml. 
Serum cholesterol assays 
Serum total cholesterol was determined enzymadcally by using Sigma 
Diagnostics cholesterol reagent (Sigma, St. Louis, MO) in a modification of 
the method of Allain et al. (24). Serum HDL-cholesterol was determined by 
using Sigma Diagnostics HDL-cholesterol reagent. It is foiTnulated according 
to the recommendations of Warnick et al. (25). Dextran sulfate and Mg ions 
were used to precipitate LDL and VLDL. Serum ti'iglyceride was determined 
by using Sigma Diagnostics triglyceride reagent in a modification of the 
method of McGowan et al. (26). LDL-cholesteroI was calculated according to 
the formula developed by Friedewald et al. (27): LDL-cholesterol = Total 
cholesterol - HDL-cholesterol - triglycerides/5. 
Protein analysis 
Protein was measured by the method of Lowry et al. (28) using bovine 
serum albumin as the standard. 
Statistical analysis 
All analyses were done in duplicate for each sample. Data were 
analyzed by using General Linear Model (SAS Institute, Cai'y, NC). Least 
Square Difference of the Statistical Analysis System (SAS Institute, Gary, 
NC) was used to test the significance between means of treatments. Two-way 
ANOVA analysis was used to determine the interaction between increasing 
dietary linoleate and vitamin E supplementation. A p<0.05 was taken to be 
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statistically significant. 
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RESULTS 
Animals and diets 
There was no difference in food intake, liver weight, and body weight 
gain of rats fed 11 or 18 en% linoleate (Fig. 1). The liver weight as 
percentage of body weight was not different due to en% linoleate (Fig. 2). 
There was no difference in food intake and body weight gain of rats fed 0, 100 
or 5000 ppm vitamin E, however, liver weight was significantly greater in the 
group receiving 5000 ppm vitamin E than in the group receiving 100 ppm 
vitamin E (10.4+0.8 vs 9.7+0.7 g) (Fig. 3). The liver weight as a percentage 
of body weight was significantly greater in the group receiving 5000 ppm 
vitamin E than in the group receiving 100 ppm vitamin E (2.6+0.1 vs 
2.5+0.1%) (Fig. 4). 
Serum vitamin E 
Vitamin E level was measured in serum. There was no difference in 
serum vitamin E of rats fed 11 or 18 en% linoleate (12.5+12.2 vs 11.8+12.2 
|Lig/ml) (Fig. 5). There was significant difference in serum vitamin E of rats 
fed 0, 100 or 5000 ppm vitamin E (non detectable, 8.8±2.0, 27.1 ±3.9 M-g/ml, 
respectively) (Fig. 6). 
Lipid status 
Serum total cholesterol, HDL-cholesterol, LDL-cholesterol and HDL-
cholesterol/LDL-cholesterol ratio (106.8±5.9 vs 103.1±7.9 mg/dl; 81.2±8.9 vs 
78.9+8.0 mg/dl; 10.7+3.2 vs 13.3+6.0 mg/dl; 8.1+3.1 vs 7.4±3.3) were not 
different in rats fed 11 or 18 en% linoleate (Fig. 7). But, serum triglyceride 
level was significantly greater in the 11 en% linoleate group than the 18 en% 
linoleate group (76.6±11.8 vs 67.4±13.7 mg/dl) (Fig. 7). There were no 
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differences in total cholesterol, triglyceride and LDL-cholesterol 
concentrations of rats fed 0, 100 or 5000 ppm vitamin E (102.8+8.5, 
104.6±6.8, 107.6±5.5 mg/dl, respectively; 72.0110.9, 69.3+13.2, 74.8±16.3 
mg/dl, respectively; 12.9+5.0,12.2+5.0, 10.9+5.0 mg/dl, respectively) (Fig. 
8). But, HDL-cholesterol level was significantly greater in the rats fed 100 
and 5000 ppm vitamin E than in the vitamin E-deficient rats (81.6+5.7, 
84.9±4.8,73.6±9.8 mg/dl, respectively). The HDL-cholesterol/LDL-
cholesterol ratio was significantly greater in the group fed 5000 ppm vitamin 
E than in the groups fed 100 and 0 ppm vitamin E (9.9±3.9, 7.1+2.4, 6.2±1.8, 
resepctively) (Fig. 8). 
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DISCUSSION 
Vitamin E concentration was determined in serum. Different en% 
linoleate did not affect serum vitamin E level, but different vitamin E 
treatments caused significantly different serum vitamin E levels (Fig. 5,6). 
These results were consistent with those of Lehmann and Dymsza and Park 
(29,30) who found that plasma a-tocopherol values progressively increased 
with larger doses of dietary a-tocopherol. 
It is well established that cholesterol has an important role in 
atherosclerosis. Epidemiological studies have shown an inverse association of 
HDL-cholesterol with the incidence of coronary heait disease (CHD). Castelli 
et al. (31) conducted a study including 7000 men and women from five 
populations in the US. The mean HDL-cholesterol concenti'ation was lower in 
subjects with CHD than in subjects without CHD. The difference was small 
(3-6 mg/dl) but statistically significant. In another portion of the Framingham 
study, nearly 3000 men and women 49-82 yeai's old were followed for about 
four years (32). Plasma HDL-cholesterol level was shown to be the most 
potent lipid risk factor in both sexes (p<0.0001). In Israel, Goldbourt and 
Medalie (33) conducted a five-year prospective study included approximately 
10,000 men 40 years or older. Serum HDL-cholesterol level was measured in 
an apparently representative subsample of 6562 men. A significant inverse 
correlation between HDL-cholesterol and subsequent CHD was observed in 
men over 45 but not in those under 45 years old. 
In the present study, vitamin E deficiency significantiy diminishes 
serum HDL-cholesterol concenUation. The mechanism of action of vitamin E 
deficiency to alter HDL-cholesterol is not cleai", but vitamin E may regulate 
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HDL-cholesterol synthesis, transport and/or breakdown. Vitamin E 
deficiency causes oxidative stress (12). Katayama and coworkers (16) showed 
that xenobiotic oxidative stressors such as phénobarbital increase serum total 
cholesterol, HDL-cholesterol and LDL-cholesterol. However, under the 
oxidative stress of vitamin E deficiency, HDL-cholesterol decreases, whereas 
LDL-cholesterol and total cholesterol are not altered. Perhaps oxidative stress 
stimulates HDL-cholesterol synthesis and transport. In human studies, the 
effect of vitamin E on lipoprotein cholesterol distribution has been 
controversial (7,17,34,35,36). This could be due to difficulty in controlling 
other factors known to influence lipoprotein levels, such as diet, body weight, 
smoking, exercise and drug effects (37). 
The effect of dietary fat manipulation on plasma triglyceride levels has 
been studied by many laboratories. Durrington et al. (38) conducted a human 
study, and demonstrated a 19.7% reduction in serum triglyceride levels when 
a high-polyunsaturated diet (18 en%) was fed. Mcintosh et al. (39) used 
monkeys to study the effect of polyunsaturated fat on plasma triglyceride 
concentration, they detected a significant fall in triglycerides when animals 
were supplemented with linoleate as a source of sunflower seed oil. The 
serum triglyceride results were consistent with those found in previous 
studies. The mechanism of dietary polyunsaturates on semm triglyceride level 
could be due to action of polyunsaturates on lipoprotein lipase. This enzyme 
of lipoprotein metabolism hydrolyzes unsaturated triglycerides faster than 
saturated triglyceride (40). Kinsell et al. (41) in a human study showed that 
there was an association between atherosclerosis and plasma C18:2/C18:l 
ratio. Greater plasma C18:2/C18:l ratio was related to lower atherosclerosis 
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incidence. Low platelet C18:2/C18:l ratio was affected by en% linoleate and 
vitamin E supplementation in the present study. Greater en% linoleate and 
vitamin E supplementation resulted in higher platelet C18:2/C18:l ratio. This 
indicates that en% linoleate and vitamin E supplementation might play a role 
in preventing atherosclerosis based on the observation of Kinsell et al. (41). 
In conclusion, with the exception of serum Uiglyceride, dietary linoleate 
composition had little effect on semm lipid levels. Increasing dietary linoleate 
decreased serum triglyceride concentration. Vitamin E supplementation did 
not affect serum lipid levels. Vitamin E deficiency decreased serum HDL-
cholesterol level. There was no interaction between increasing dietary 
linoleate and vitamin E status in lipid levels. The present study suggests that 
vitamin E deficiency can be atherosclerotic by virtue of its inhibitory effect on 
serum HDL-cholesterol level by mechanisms which are as yet unclear, but 
may be due to oxidative stress. 
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Table 1. Composition of experimental diets 
Energy Percentage 
Linoleate^ 
Ingredient 11 ^ 
• g/lOOg 
Lard, tocopherol-stripped^ 7.2 — 
Com Oil, tocopherol-strippedb 7.2 14.3 
Casein "Vitamin Free" Test^ 22.4 22.4 
Sucrose^ 26.4 26.4 
Com Starch^ 26.4 26.4 
Cellulose^ 5.0 5.0 
AIN Mineral Mixture 76bc 3.9 3.9 
Vitamin Mixture (a-tocopherol 1.1 1.1 
devoid)bd 
Tocopheryl Acetate^ p
 
o
 
o
 
0.5 0, 0.01, 0.5 
L-Methionineb 0.3 0.3 
Choline Chloride^ 0.08 0.08 
Ascorbic Acid (antioxidant)b 0.01 0.01 
Cholesterol (mg/100 g)b 0 6.8 
^Each level of linoleate was fed with 0, 100 or 5000 ppm a-tocopheryl 
acetate. 
bTeklad, Madison, WI. 
^Composition described by the AIN Ad Hoc Committee on Standards for 
Nutritional Studies, 1977 (19). 
^Composition described by the AIN Ad Hoc Committee on Standards for 
Nutritional Studies, 1977 (19), except that vitamin E acetate was substituted 
by sucrose. 
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Table 2. Fatty acids composition of experimental diets 
11 en% linoleate 18 en% linoleate 
% 
14 1.0 —• 
15 0.1 
16 18.1 10.2 
16:1 2.1 — 
18 5.5 1.8 
18:1 33a 23.9 
18:2 37.5 62.0 
18:3 1.1 2.1 
20:1 0.6 
20:2 0.2 
P/S ratio 
P/M ratio 
1.6 
1.1 
5.4 
2.7 
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18 en% Lin 
11 en% Lin 
Liver Wt Bd Wt Gain Food Intake 
Figure 1. Effect of en% linoleate on liver weight, body weight gain and food 
intake. Groups that do not share the same letter aie significantly 
different from one another, p<0.05 
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4-1  
g 18 en% Lin 
11 en% Lin 
3-
2 -
1 -
0 
a 
T 
Liver Wt/BW 
Figure 2. Effect of en% linoleate on liver weight as percentage of body 
weight. Groups that do not share the same letter aie significantly 
different from one another, p<0.05 
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1 6  
Vit E 0 ppm 
VitE 100 ppm 
Vit E 5000 ppm 
1 6  
1 2 -
8 -
0 
a 
T 
a a 
a a 
fîSïSfSÎ: 
iîSÎSiSîi 
ïfSïïiKiS 
• 1 2  . S  
a 
.. 
• 4  
0 
Liver Wt Bd Wt Gain Food Intake 
Figure 3. Effect of vitamin E status on liver weight, body weight gain and 
food intake. Groups that do not share the same letter ai'e 
significantly different from one another, p<0.05 
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3 Vit E 0 ppm 
VitE 100 ppm 
Vit E 5000 ppm 
1 -
G 
a 
X. 
Liver Wt/BW 
Figure 4. Effect of vitamin E status on liver weight as percentage of body 
weight. Groups that do not share the same letter ai'e significantly 
different from one another, p<0.05 
100 
2 18en%Lm 
H 11 en% Lin 
30-1 
s 
s  2 0 -
a 
o 
g 
s O 
U 
Serum Vitamin E 
Figure 5. Effect of en% linoleate on serum vitamin E level. Groups that do 
not share the same letter aie significantly different from one 
another, p<0.05 
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s 
40-1 
2 0 -
Vit E 0 ppm 
Vit E 100 ppm 
Vit E 5000 ppm 
Serum Vitamin E 
Figure 6. Effect of vitamin E supplementation on serum vitamin E level. 
Groups that do not share the same letter aie significantly different 
from one another, p<0.05 
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1 5 0  
1 2 0 -
90 
6 0 -
3 0 -
0 1 
I 
WÊÊà 
a 
1 
3 18 en% Lin 
11 en% Lin 
i 
a 
X 
b 
« j 
Àil  /// 
a a 
1 5 0  
- 1 2 0  
- 9 0  
- 6 0  
30 
LO 
HDL TC TG LDL HDL/LDL 
P 
M 
«H O 
Figure 7. Effect of en% linoleate on serum lipid levels, and HDL-
cholesterol/LDL-cholesterol ratio. Groups that do not share the 
same letter are significantly different from one another, p<0.05 
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^ Vit E 0 ppm 
Vit E 100 ppm 
Vit E 5000 ppm 
1 2 0 -
1 4 0  
1 2 0  
a a 
a a 
- 1 0 0  i J  
HDL TC TG LDL HDL/LDL 
Figure 8. Effect of vitamin E status on serum lipid levels and HDL-
cholesterol/LDL-cholesterol ratio. Groups that do not shaie the 
same letter are significantly different from one another, p<0.05 
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GENERAL SUMMARY 
Platelet Fatty Acids 
The changes in platelet fatty acid composition due to different dietary 
treatments were consistent with results of Piche and Mahadevappa (50) and 
Iritani and Narita (52). Platelet arachidonic acid level was greatest in the 
vitamin E-deficient group. This suggests that vitamin E deficiency and other 
oxidative stressors could affect fatty acid desaturation and elongation. 
Mcintosh et al. (88) observed that vitamin E increased or decreased platelet 
phospholipid arachidonic acid depending on dietaiy treatments. In a basal diet 
which supplied 1.2% (w/w) sunflower seed oil, vitamin E supplementation 
decreased platelet phopholipid arachidonic acid. But, after increasing 
sunflower seed oil to 10% (w/w), vitamin E supplementation increased 
platelet phopholipid arachidonic acid. However, in the present study, dietary 
linoleate ranging from 11 to 18% and vitamin E supplementation did not 
further stimulate platelet arachidonate. The role of vitamin E in fatty acid 
desaturation and elongation needs further study. 
Prostaglandin Status 
Effects of dietary fat on prostaglandin biosynthesis have been studied 
by Dupont et al. (55), Sullivan and Mathias (56) and Mathias and Dupont 
(57). Greater en% linoleate was not correlated with increased prostaglandin 
production in these studies, and 2 en% linoleate was found to be optimal for 
prostaglandin synthesis. Varying the dietai'y P/S ratios has also been found to 
affect prostaglandin synthesis (57). Dietaiy P/S ratios between 0.4 and 5.5 did 
not significantly affect serum prostaglandin levels while a dietai'y P/S ratio of 
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9 was found to increase serum prostaglandin levels markedly (89). In the 
present study, en% supplied by linoleate was in the range of 10 to 29 which 
had no effect on prostaglandin synthesis and the dietary P/S ratios, well within 
the ranges of 0.4 and 5.5, also did not affect prostaglandin production. 
Studies examining the effect of dietary vitamin E on prostaglandin 
synthesis have not given a consistent picture. We found no effect of vitamin E 
on prostacyclin (PGI2) synthesis in this study which was in agreement with 
the work of Stampfer et al. (46). Thromboxane A2 production was increased 
by vitamin E deficiency. Karpen et al. reported the same results (48). 
Inconsistent results obtained by different laboratories could be due to different 
amount of vitamin E fed in the ranges of 0 to 1000 mg/kg diet, differences in 
feeding period from 8 to 23 weeks, species vaiiation, for example rats, rabbits 
and humans and different tissue sampling and preparation. The balance 
between TXA2 and PGI2 is important, because platelet aggregation and 
vasoconstriction play important roles in atherosclerosis. The serum 
TXA2/PGI2 ratio was significantly greater in rats receiving no vitamin E 
compared with the ratio when 5000 ppm vitamin E was fed. Results of the 
present study indicates that vitamin E deficiency may have a prothrombotic 
effect through its role on TXA2 status. Vitamin E deficiency can increase 
oxidative stress and platelet arachidonic acid concentration. Greater platelet 
arachidonic acid might increase TXA2 production because aiachidonate is the 
prostaglandin precursor. Therefore, vitamin E deficiency might increase 
TXA2 in 2 ways by increasing TXA2 precursor and by increasing oxidative 
stress-mediated TXA2 production by as yet unknown mechanisms. 
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Platelet Phospholipase A2 activity 
Neither en% linoleate nor vitamin E supplementation affected platelet 
phospholipase A2 activity. However, C18:2n-6 was negatively correlated 
with phospholipase A2 activity (r=-0.41, p<0.05) which indicates an inhibition 
of phospholipase A2 activity by polyunsaturated fatty acids. These results 
were observed in work by Ballou and Cheung (83). Tangney and Driskell 
(90) demonstrated that vitamin E inhibited platelet phospholipase A2 activity. 
The mechanism by which vitamin E influences platelet phospholipase A2 
activity is not clear. In the present study, vitamin E did not affect endogenous 
platelet phopsholipase A2 activity. Perhaps these results differed from those 
of Tangney and Driskell because of the absence of thrombin-induction during 
the measurement of phospholipase A2 activity. 
Platelet and Serum Vitamin E Levels 
Both platelet and serum vitamin E levels reflected dietary vitamin E. It 
has been long recognized that the amount of vitamin E required to prevent 
lipid peroxidation depends on the dietary intake of fat, paiticularly the intake 
of polyunsaturated fatty acids (91). In the present study, linoleate contributed 
11 and 18 en%. Even though there was a difference in platelet linoleate 
levels, differences in platelet vitamin E concentration were not detected. It 
was indicated by Chan et al. (92) that the retention of tocopherol by rat 
platelets appeared to be logarithmatically related to increasing vitamin E 
concentrations in the diets. The results in the present study tended to be 
logarithmic related to increasing dietary vitamin E concentration in agreement 
with the experiments of Chan et al. 
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Serum Lipid Levels 
It is well established that cholesterol has an important role in 
atherosclerosis. HDL-cholesterol has an inverse relation vyith risk of coronary 
heart disease (5,6), while LDL has a positive relation with the incidence of 
coronary heart disease. In the present study, vitamin E deficiency caused 
significantly lower serum HDL-cholesterol concentrations. The mechanism 
by which vitamin E deficiency suppresses HDL-cholesterol is not clear but the 
lack of vitamin E stimulates oxidative stress, which might regulate HDL-
cholesterol levels. Phénobarbital and Cu deficiency aie oxidative stressors 
(95,96), both are found to increase serum and plasma total cholesterol 
concentrations. However, under the oxidative stress of vitamin E deficiency 
serum total cholesterol is not altered. The role of vitamin E and oxidative 
stress in the regulation of HDL-cholesterol needs further study. 
Manipulations of dietary fat can affect plasma triglyceride levels. An 
increase in dietary PUFA will decrease triglyceride has been shown in many 
studies (88,93). Mcintosh et al. (88) showed that the diets supplemented with 
linoleate produced a significant fall in plasma triglyceride levels. Dumngton 
et al. (94) found that differences in en% from PUFA (4% vs 18%) produced 
significantly different serum triglyceride levels, and greater en% from PUFA 
resulted in less serum triglyceride. Semm triglyceride concentrations in our 
study were consistent with the results found by previous studies. The 
mechanism of the effect of dietary linoleate on serum tiiglyceride level could 
be due to the action of lipoprotein lipase on polyunsaturated fatty acids. This 
enzyme, involved in lipoprotein metabolism, hydrolyzes unsaturated 
triglycerides faster than 
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saturated triglycerides (94). 
The present study suggests that vitamin E deficiency might be a cause 
of atherosclerosis because it can be prothrombogenic by virtue of its 
stimulatory effect on TXA2 synthesis. Vitamin E deficiency can also suppress 
HDL-cholesterol. En% linoleate between 11 and 18 en% did not affect 
prostaglandin status but it did decrease serum triglyceride level when 18 en% 
linoleate was substituted for 11 en% linoleate. Dietary linoleate and vitamin E 
status did not interact in altering atherosclerotic risk factors. Vitamin E 
supplementation did not seem to benefit any of the atherosclerotic risk factors 
studied. 
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